US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of concern. In the prospective study, ...

The advanced development of medical technology has accelerated in recent years, with devices being continuously manufactured for healthcare professionals as well as consumers at home. From wellbeing ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company designing non-invasive tools to better equip primary care physicians for skin cancer detection, today announced the publication of ...

The Food and Drug Administration (FDA) has approved DermaSensor's groundbreaking AI-powered medical device, marking a pivotal moment as the first artificial intelligence-driven tool designed to assist ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company's COO discussed its ...

The Food and Drug Administration has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients. The technology, from ...

MIAMI--(BUSINESS WIRE)--DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for use in evaluation of suspicious skin lesions, presented to ...

The FDA has cleared DermaSensor’s first-of-its-kind handheld device that uses artificial intelligence to non-invasively detect skin cancer, the Miami-based device maker announced Wednesday. Physicians ...

Medtech company DermaSensor has claimed FDA approval for a handheld device, powered by artificial intelligence (AI), that can be used to detect skin cancer at the point of care. The eponymous device, ...